| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2015 | EP2821105A1 Ingenol derivatives in the reactivation of latent hiv |
| 01/07/2015 | EP2821104A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 01/07/2015 | EP2821083A1 Combined use of amides of mono- and dicarboxylic acids and silymarin in the treatment of renal diseases |
| 01/07/2015 | EP2821072A1 Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord disorders |
| 01/07/2015 | EP2821071A1 Compounds for breast cancer treatment |
| 01/07/2015 | EP2821070A1 Adhesive skin patch |
| 01/07/2015 | EP2821069A1 Enhancer for eating activity and/or gastrointestinal activity |
| 01/07/2015 | EP2821068A1 Pharmaceutical composition for preventing or treating hepatic fibrosis and cirrhosis containing ramalin |
| 01/07/2015 | EP2821067A1 Rapid dissolution formulation of cinacalcet |
| 01/07/2015 | EP2821066A2 High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient |
| 01/07/2015 | EP2821065A1 Percutaneous absorption preparation containing donepezil, and method for preparing same |
| 01/07/2015 | EP2821062A1 Novel dry powder inhaler formulations |
| 01/07/2015 | EP2821061A1 Novel inhalation formulations |
| 01/07/2015 | EP2820148A1 Screening assays for identifying and validating agents that target cancer stem cells |
| 01/07/2015 | EP2820131A2 Use of micro-rnas or genes as markers for the identification, diagnosis and therapy of individual forms of non-ischemic cardiomyopathies or storage diseases of the heart |
| 01/07/2015 | EP2820130A1 Rhogef12 is a therapeutic target for the treatment of heart failure |
| 01/07/2015 | EP2820050A1 Hypoglycemic hyper-branched maltodextrins |
| 01/07/2015 | EP2820022A1 Furo [2, 3 -c]pyridines actives on gpr 119 |
| 01/07/2015 | EP2820021A1 Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharmaceutical composition comprising the same |
| 01/07/2015 | EP2820020A1 Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhinitors |
| 01/07/2015 | EP2820019A1 Novel crystalline form of sitagliptin sulfate |
| 01/07/2015 | EP2820018A1 Amido-benzyl sulfone and sulfoxide derivatives |
| 01/07/2015 | EP2820017A1 Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
| 01/07/2015 | EP2820016A1 N- (5s, 6s, 9r) - 5 -amino- 6 - (2, 3 - difluorophenyl) -6, 7, 8, 9 - tetrahydro - 5h - cyclohepta [b]pyridin-9 -yl- 4 - (2 - oxo-2, 3 - dihydro - 1h- imidazo [4, 5 -b]pyridin - 1 - yl) piperidine - 1 - carboxylate, hemisulfate salt |
| 01/07/2015 | EP2820014A1 Heterobicyclic compounds and their use as phosphodiesterase inhibitors |
| 01/07/2015 | EP2820013A1 Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions |
| 01/07/2015 | EP2820010A1 Benzofuran- 2 - sulfonamide derivatives as chemokine receptor modulators |
| 01/07/2015 | EP2820009A1 Serine/threonine kinase inhibitors |
| 01/07/2015 | EP2820008A1 Amido spirocyclic amide and sulfonamide derivatives |
| 01/07/2015 | EP2820007A1 4,4-difluoro-piperidine-compounds |
| 01/07/2015 | EP2820006A1 Pyrazol-1-yl benzene sulfonamides as ccr9 antagonists |
| 01/07/2015 | EP2820005A1 Phenyl alkanoic acid derivatives as gpr agonists |
| 01/07/2015 | EP2820001A1 Sodium and calcium salts of a dihydroquinazoline derivative and use thereof as antiviral agents |
| 01/07/2015 | EP2820000A1 Besylate and tosylate salts of a dihydroquinazoline derivative and use thereof as antiviral agents |
| 01/07/2015 | EP2819999A1 Spirohydantoin compounds and their use as selective androgen receptor modulators |
| 01/07/2015 | EP2819990A1 Bio-polyols for bio-lubricant and bio-polymer and methods for the preparation thereof |
| 01/07/2015 | EP2819982A1 Prodrugs of vitamine k |
| 01/07/2015 | EP2819699A1 Controlled release compositions and their methods of use |
| 01/07/2015 | EP2819691A1 Methods for activating retrovirus in latent infected cells, and compounds for use therein |
| 01/07/2015 | EP2819690A2 Method of treating chronic obstructive pulmonary disease |
| 01/07/2015 | EP2819687A1 Compositions and methods for treatment of peripheral vascular disease |
| 01/07/2015 | EP2819685A1 Methods and compositions for enhancement of vision performance |
| 01/07/2015 | EP2819683A1 Use of a glycosylated-modified tetrafunctional non-ionic amphiphilic block copolymer as immune adjuvant |
| 01/07/2015 | EP2819682A1 Topical gels containing alpha connexin c-terminal (act) peptides |
| 01/07/2015 | EP2819681A1 Method for improving functional synaptic connectivity |
| 01/07/2015 | EP2819680A1 Method for enhancing efficacy and selectivity of cancer cell killing by dna damaging agents |
| 01/07/2015 | EP2819679A1 Liquid formulations of hypoglycaemic sulphonamides |
| 01/07/2015 | EP2819678A1 Process to improve feed efficiency and carcass characteristics of animals |
| 01/07/2015 | EP2819677A1 Combination of selective progesterone-receptor modulators and nonsteroidal anti-inflammatory drugs |
| 01/07/2015 | EP2819676A1 Combination therapy for treating androgen deficiency |
| 01/07/2015 | EP2819675A1 Salts of potassium atp channel openers and uses thereof |
| 01/07/2015 | EP2819674A2 Compositions and methods for the treatment of migraine |
| 01/07/2015 | EP2819673A2 Pharmaceutical compositions comprising boronic acid compounds |
| 01/07/2015 | EP2819672A1 Inhalable dry powders |
| 01/07/2015 | EP2819671A2 Binhibitors of hepatitis b virus convalently closed circular dna formation and their method of use |
| 01/07/2015 | EP2819670A1 Pharmaceutical composition and administration thereof |
| 01/07/2015 | EP2819669A1 Novel propellant-gas-containing tiotropium formulation |
| 01/07/2015 | EP2819668A1 Ritonavir compositions |
| 01/07/2015 | EP2819667A1 Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency |
| 01/07/2015 | EP2819666A1 Gelling formulation based on calcium gluconate |
| 01/07/2015 | EP2819665A1 Protease inhibitors for treating trichomonas gallinae infections |
| 01/07/2015 | EP2819664A1 New compositions for treating amyotrophic lateral sclerosis |
| 01/07/2015 | EP2819663A1 New therapeutic approaches for treating parkinson's disease |
| 01/07/2015 | EP2819662A1 Reprogramming effector protein interactions to correct epigenetic defects in cancer |
| 01/07/2015 | EP2819661A2 Potent anticancer activity via dual compound activation |
| 01/07/2015 | EP2819660A1 Transdermal device including porous microparticles |
| 01/07/2015 | EP2819658A2 Pharmaceutical formulation containing flupirtine |
| 01/07/2015 | EP2819657A1 Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant |
| 01/07/2015 | EP2819656A1 Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
| 01/07/2015 | EP2819655A1 Use of modafinil in the treatment of cocaine addicts |
| 01/07/2015 | EP2819654A1 Process for obtaining a modafinil-based pharmaceutical composition, resulting pharmaceutical composition and use thereof |
| 01/07/2015 | EP2819653A2 Tamper resistant immediate release formulations |
| 01/07/2015 | EP2819650A1 Hormone containing emulsion comprising krill phospholipids |
| 01/07/2015 | EP2819649A1 Hormone containing emulsion |
| 01/07/2015 | EP2819648A1 Pharmaceutical preparation containing an antivirally active dihydroquinazoline derivative |
| 01/07/2015 | EP2819646A1 Spinal fusion system for osteoporotic vertebrae |
| 01/07/2015 | EP2819645A2 Inhalable pharmaceutical compositions |
| 01/07/2015 | EP2819644A1 Spray dried formulations |
| 01/07/2015 | EP2819635A1 Combination product for treating excess weight and/or for improving the figure |
| 01/07/2015 | EP2819517A2 Small molecule having antiviral properties |
| 01/07/2015 | EP2819516A1 Use of (1r,5s)-(+)-1-(naphthalen-2-yl)-3-azabicyclo{3.1.0}hexane in the treatment of conditions affected by monoamine neurotransmitters |
| 01/07/2015 | CN204072820U 一种用于治疗幽门螺杆菌的复方三层片 A three-piece compound treatment for Helicobacter pylori |
| 01/07/2015 | CN104271756A 肌肉肌醇和肌肉肌醇衍生物的制造方法 Manufacturing method myo-inositol and myo-inositol derivatives |
| 01/07/2015 | CN104271742A 微小rna抑制剂 Small rna inhibitors |
| 01/07/2015 | CN104271741A 用于治疗神经肌肉障碍的具有改善特性的rna调节寡核苷酸 Rna for the treatment of neuromuscular disorders with improved characteristics adjustment oligonucleotide |
| 01/07/2015 | CN104271581A 用作电压门控钠通道调制剂的2-(吡啶-2基)-1,7-二氮杂螺[4.4]壬-6-酮化合物 As a voltage-gated sodium channel modulators of 2- (pyridin-2-yl) -1,7-spiro [4.4] non-6-one compound |
| 01/07/2015 | CN104271580A 吡咯并三嗪酮衍生物 Pyrrolotriazine derivatives |
| 01/07/2015 | CN104271579A 作为生长素释放肽受体激动剂的2,7-二氮杂-螺[4,5]癸烷-7-基衍生物的l-苹果酸盐及其结晶 As the ghrelin receptor agonist 2,7-diaza - spiro [4,5] decane-7-yl derivative l- malate and crystallization |
| 01/07/2015 | CN104271578A 作为lrrk2调节剂用于治疗帕金森病的吡唑氨基嘧啶衍生物 As lrrk2 modulators for the treatment of Parkinson's disease pyrazole amino pyrimidine derivatives |
| 01/07/2015 | CN104271576A 激酶的吡啶并嘧啶酮抑制剂 Kinase inhibitors pyrido pyrimidinone |
| 01/07/2015 | CN104271574A 杂环化合物 Heterocyclic Compounds |
| 01/07/2015 | CN104271573A (1-(4-氟苯基)-1h-吲哚-5-基)-(3-(4-(噻唑-2-羰基)哌嗪-1-基)氮杂环丁-1-基)甲酮的结晶盐酸盐及其治疗疼痛和代谢紊乱的用途 (1- (4-fluorophenyl) -1h- indol-5-yl) - (3- (4- (thiazol-2-carbonyl) piperazin-1-yl) azetidin-1-yl) crystalline hydrochloride and its use for treating pain and metabolic disorders methanone |
| 01/07/2015 | CN104271572A 用作nampt抑制剂的噻唑羧酰胺衍生物 Inhibitors used nampt thiazole carboxamide derivatives |
| 01/07/2015 | CN104271569A 作为lrrk2调节剂的吡唑氨基嘧啶衍生物 As pyrazole-aminopyrimidine derivative lrrk2 moderator |
| 01/07/2015 | CN104271566A 取代的联吡啶胺及其用途 Substituted bipyridyl amine and their use |
| 01/07/2015 | CN104271565A 酰胺吡啶衍生物及其用途 Amide pyridine derivatives and their use |
| 01/07/2015 | CN104271561A 苯丙醇类抗菌剂 Phenylpropanoid alcohol antibacterial agent |
| 01/07/2015 | CN104271558A β-分泌酶抑制剂 β- secretase inhibitors |
| 01/07/2015 | CN104271557A 去泛素化活性的抑制方法 Deubiquitination activity Suppression |
| 01/07/2015 | CN104271554A 取代的吡咯烷-2-甲酰胺 Substituted pyrrolidine-2-carboxamide |